January 16 2008

VeriChip Corporation Announces Changes to Board of Directors to Remove all Overlap with Digital Angel

DELRAY BEACH, FL – January 16, 2008 –VeriChip Corporation (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, today announced a series of changes to its Board of Directors to remove all overlap between its Board and Digital Angel’s Board. Constance K. Weaver and Daniel E. Penni, who serve on the Digital Angel Board, have stepped down from the VeriChip Board, and Barry M. Edelstein, has stepped down from the Digital Angel Board and joined the VeriChip Board. These changes create two independent Boards of Directors with no common Board members.

About VeriChip

VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed^(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip^(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.

For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.

###

CONTACTS:

Dan Schustack

CEOcast

212-732-4300

dschustack@ceocast.com

Allison Tomek

VeriChip Corporation

(561) 805-8008

atomek@adsx.com